New York Mets, Reliever, Ryan Helsley

...

Patrick McAvoy

By Patrick McAvoy

Contributing Sports Writer

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


The Toronto Blue Jays clearly haven't taken their foot off the gas since losing the World Series against the Los Angeles Dodgers.

Toronto seemingly is aggressive each offseason. The Blue Jays were involved in the Shohei Ohtani, Juan Soto, and Rōki Sasaki markets over the last two offseasons, to name a few. Toronto already has had success this offseason by reportedly agreeing to sign Dylan Cease to a long-term deal.

There have been misses as well, though. For example, The Athletic's Mitch Bannon shared on X that the Blue Jays showed at least "preliminary interest" in Ryan Helsley, Raisel Iglesias, and Phil Maton in free agency.

Read More on MLB

NEW YORK, NEW YORK - SEPTEMBER 12: (NEW YORK DAILIES OUT)  Ryan Helsley #56 of the New York Mets in action against the Texas Rangers at Citi Field on September 12, 2025 in New York City. The Rangers defeated the Mets 8-3. (Photo by Jim McIsaac/Getty Images)

...

"The Blue Jays showed at least preliminary interest in the 3 top (relief pitchers) to sign so far (Iglesias, Maton, and Helsley)," Bannon wrote on X. "They remain interested in adding a 7th to 9th inning arm."

This report surfaced after Helsley reportedly agreed to a two-year deal with the Baltimore Orioles on Saturday, per ESPN's Jeff Passan.

"Closer Ryan Helsley and the Baltimore Orioles are in agreement on a two-year contract with an opt-out after the first season, pending physical, sources tell ESPN," Passan wrote on X. "Helsley, who fielded interest from teams to convert to a starter, will be the ninth-inning option for Baltimore."

The Blue Jays could use a high-leverage reliever. Helsley, Iglesias, and Maton all would've been good options. Fortunately, there are others still available.

More MLB: How Blue Jays’ Reported Dylan Cease Deal Already Looks Genius

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines